- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02358915
A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Survivors of spinal cord injury (SCI) usually have severe mobility limitation due to their paralysis.In order to improve the independence of living for those patients, scientists and engineers invented many different types of assistive devices, such as breath controlled "sip and puff" devices, speech controlled devices, eye movement controlled devices, and head movement controlled devices. However, one limitation of the previous designs is that they all require usurping the intact function of a functional organ like mouth or eyes. A recent design by Reach Bionic's company takes advantage of a set of ear muscles-the peri-auricular muscles-that are present in more than 95% of the population, but do not serve any physiologic function in humans. These muscles are innervated by branches of cranial nerves that are controlled through the brain stem, above the spinal cord. Therefore, it is unlikely they will be affected even by a very high SCI. The design intention is to translate the ear contraction signal from the muscles into the meaningful control signal to direct a wheelchair or operate a computer cursor in a fashion to a joystick or mouse. However, since most people do not have the ability to voluntarily contract their ear muscles, the question remains how to best learn to contract our ear muscles and design an effective training paradigm.
Since norm volunteers will have the same voluntary control of their peri-auricular muscles as the patients suffering from spinal cord injury, thus, the investigators are going to test the effectiveness of our two-step training paradigm among the healthy participants at this explorative stage.
In specific, at the first step of training, participants will be asked to voluntarily contract their ear muscles with the facilitation of electrical stimulation. At the second step of training, they will take part in a computer game and will be asked to move a cursor to a specific target that will randomly appear on the computer screen. The cursor will be controlled by the electrical activities produced by the ear muscles contractions that will be captured by surface electromyography (EMG) signals.
The computer game performance of each participant before and after the second step of training with surface EMG signals feedback and the mean surface EMG signal amplitude of the auricular muscles at the maximum voluntary contraction at baseline, after the first step of training, and after the second step of training will be compared.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Tidlig fase 1
Kontakter og lokationer
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90089
- University of Southern California-Health Sciences Campus
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- healthy participants
- can't control their peri-auricular muscles at the beginning of the study (no visible movement of the ears on command).
Exclusion Criteria:
- Suffering any comorbid neuromuscular disease.
- Having a history of severe traumatic brain injury.
- Demonstrating cognitive impairment that would prevent them from providing inform consent or following the directions of the study protocol.
- Having a history of migraine headaches that could be exacerbated with the use of the electrical stimulation or the prolonged training sessions.
- Temporomandibular Joint (TMJ) dysfunction that could lead to unusual discomfort following training session.
- Having a history of prior seizure.
- Being implanted with pacemaker or defibrillators.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Peri-auricular muscles voluntary contraction training paradigm
The whole training paradigm consists of two steps.
At the first step of training, the electrical stimulation (FastStart neuromuscular electrical stimulator) will be applied to facilitate the voluntary contractions of the ear muscles, and the motion of the outer ear in two directions (up/down, forward/backward) will be videotaped and played back to the participants so that they can get real-time visual feedback about their ear movement.
At the second step of training, surface EMG electrodes will be placed on the skin around participants' ears.
During the training, they are required to move a cursor to a specific target that will randomly appear on the computer screen.
The cursor will be controlled by the electrical signal from the contraction of their bilateral peri-auricular muscles.
In the computer game, contraction of the left ear muscles will move the cursor to the left side and contraction of your right ear muscles will move the cursor to the right side.
|
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The surface EMG signal amplitude of the auricular muscles at the maximum voluntary contraction
Tidsramme: Up to 5 weeks
|
Up to 5 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
The computer game performance score
Tidsramme: Up to 2 weeks
|
Up to 2 weeks
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Carolee J. Winstein, Ph.D, University of Southern California
- Ledende efterforsker: Baker Lucinda, Ph.D, University of Southern California
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- HS-14-00672
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Non-disabled Volunteers
-
Marker Therapeutics, Inc.RekrutteringNon Hodgkin lymfom | Non-Hodgkin lymfom, voksen | Non-Hodgkin lymfom, refraktær | Non-Hodgkin lymfom, tilbagefaldForenede Stater
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.Ikke rekrutterer endnuLymfom | Lymfom, Non-Hodgkin | Non-Hodgkins lymfom | Non-Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Højgradigt B-celle lymfom | CNS lymfom | Lymfomer Non-Hodgkins B-celle | Recidiverende non-Hodgkin lymfom | Lymfom, Non-Hodgkins | Stort B-celle lymfom | Lymfom, Non-Hodgkins... og andre forhold
-
Stanford UniversityNational Institutes of Health (NIH); AmgenAfsluttetLymfom, Non-Hodgkin | Lymfomer: Non-Hodgkin | Lymfomer: Non-Hodgkin perifer T-celle | Lymfomer: Non-Hodgkin kutan lymfom | Lymfomer: Non-Hodgkin diffuse store B-celler | Lymfomer: Non-Hodgkin follikulært / indolent B-celle | Lymfomer: Non-Hodgkin kappecelle | Lymfomer: Non-Hodgkin Marginal Zone | Lymfomer...Forenede Stater
-
Caribou Biosciences, Inc.RekrutteringLymfom | Lymfom, Non-Hodgkin | B-celle lymfom | Non Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Recidiverende non-hodgkin lymfom | B-celle non-Hodgkins lymfomForenede Stater, Australien, Israel
-
Chongqing Precision Biotech Co., LtdRekrutteringNon Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Recidiverende non-Hodgkin lymfomKina
-
Memorial Sloan Kettering Cancer CenterRekrutteringNon-Hodgkin lymfom | Non-Hodgkins lymfom, tilbagefald | Non-Hodgkins lymfom refraktærForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringRefraktær B-celle non-Hodgkin lymfom | Tilbagevendende B-celle non-Hodgkin lymfom | Højgradig B-celle non-Hodgkins lymfom | Mellemklasse B-celle non-Hodgkins lymfomForenede Stater
-
Mayo ClinicIkke rekrutterer endnuIndolent B-celle non-Hodgkin lymfom | Tilbagevendende indolent non-Hodgkin-lymfom | Refraktært indolent non-Hodgkin lymfom | Tilbagevendende indolent B-celle non-Hodgkin lymfom | Refraktært indolent B-celle non-Hodgkin lymfomForenede Stater
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdRekrutteringRefraktær non-Hodgkin lymfom | Recidiverende non-hodgkin lymfomKina
-
Joseph TuscanoSpectrum Pharmaceuticals, IncAktiv, ikke rekrutterendeRecidiverende non-hodgkin lymfom | Refraktær non-hodgkin lymfomForenede Stater
Kliniske forsøg med FastStart neuromuscular electrical stimulator
-
Oregon Health and Science UniversityAfsluttet
-
Wolfgang Fitz, M.D.CyMedica Orthopedics, IncAfsluttetTotal knæarthroplastikForenede Stater